Article Details

AstraZeneca Enhertu secures USFDA nod for HER2-low breast cancer - Medical Dialogues

Retrieved on: 2022-08-06 09:24:20

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Enhertu secures USFDA nod for HER2-low breast cancer - Medical Dialogues. View article details on HISWAI: https://medicaldialogues.in/news/industry/pharma/astrazeneca-enhertu-secures-usfda-nod-for-her2-low-breast-cancer-97132

Excerpt

UK: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up